From GLP-1 medications to sustainable habits: realistic, no-hype guidance on weight, appetite and metabolism.
Not losing weight in a calorie deficit? It is usually tracking gaps, water retention or metabolic adaptation, not a broken metabolism. Here is how to fix it.
Read article
A natural appetite suppressant for night eating starts with protein, fibre, sleep and meal timing, not pills. Why evening hunger happens and how to calm it.
Read article
Berberine vs Ozempic for weight loss: berberine is sold as nature's Ozempic, but trials show a far smaller effect. Weight, mechanism, safety and cost compared.
Read article
How to lose belly fat after menopause: falling oestrogen moves fat to the abdomen. Here are the strength, protein and sleep changes that actually reduce it.
Read article
Incline 12, speed 3, thirty minutes. Here is what the research says about calories burned, why it works for some people, who should not do it, and its real limitation.
Read article
BMI was never designed to assess an individual. Here is what it misses, why waist-to-height ratio predicts risk better, and how to measure yourself properly in 30 seconds.
Read article
Losing weight on Ozempic or Wegovy? Exercise, especially strength training, protects the muscle these drugs can strip. Here is how to train and eat to keep it.
Read article
Feeling wiped out on Ozempic or Wegovy? Here is why these medications can cause fatigue, how long it usually lasts, and the practical ways to get your energy back.
Read article
GLP-1 medications carry a raised risk of gallstones. Here is why it happens, the warning signs to take seriously, who is most at risk, and when to seek urgent care.
Read article
Constipation is a common Ozempic and Wegovy side effect. Here is why it happens, how long it usually lasts, and the practical, evidence-based ways to find relief.
Read article
Compounded semaglutide is often cheaper, but it is not FDA-approved. Here is what it actually is, the real safety concerns, and what to weigh before considering it.
Read article
Wondering if you can still have a drink on Wegovy? Here is how alcohol and semaglutide interact, why you may feel it faster, and how to be sensible about it.
Read article
Rotten-egg burps on Ozempic or Wegovy are common and unpleasant. Here is why they happen, the foods that trigger them, and what actually helps reduce them.
Read article
Weight loss stalled on Wegovy? A plateau usually does not mean the drug stopped working. Here is why it happens and what genuinely helps you move forward.
Read article
Some people on Ozempic report wanting to drink less. Here is what the early research actually shows about semaglutide and alcohol cravings, and the honest limits.
Read article
Nausea is the most common Wegovy side effect. Here is why it happens, how long it usually lasts, and the practical, evidence-based ways to feel less sick.
Read article
Worried about hair shedding on Ozempic or Wegovy? Here is what the evidence shows about the real cause, why it is usually temporary, and how to protect your hair.
Read article
Intermittent fasting promises weight loss and a metabolic reset. Here is what the latest research really supports, why it works, and who should skip it.
Read article
Ozempic, Wegovy, Mounjaro and the new pills: real benefits, real downsides, costs, risks and who should consider them.
Read article
From week 1 to month 16: a realistic Wegovy weight-loss timeline based on trial data, including the new 7.2 mg Wegovy HD.
Read article
Alli is the only FDA-approved OTC option. What about the rest of the shelf? An honest audit of supplements vs evidence.
Read article
Social media's favourite GLP-1 hack, examined: the appeal, the risks of DIY dosing, and the legitimate version doctors use.
Read article
The world's most prescribed diet pill versus its upgraded duo: results, costs, side effects and duration rules.
Read article
Average 20.9 percent loss at 72 weeks: what Zepbound delivers, who responds best and what the averages hide.
Read article
Up to 40 percent of GLP-1 weight loss can be lean mass. The protein targets and training plan that prevent it.
Read article
Patent expiry quietly created the cheapest legitimate entry into GLP-1 therapy. Who it fits and what to check.
Read article
From 0.25 mg to the new 7.2 mg HD, plus the daily pill: every Wegovy dose, why the ladder exists and how adjustments work.
Read article
Why fast weight loss ages the face, whether the drug is to blame, prevention strategies and the options if it already happened.
Read article
Most users regain after stopping. The biology of the rebound, what the successful minority does differently, and the exit plan to build from day one.
Read article
Liraglutide vs semaglutide: results, dosing burden, price and the cases where the older daily pen still makes sense.
Read article
Needle-free GLP-1 arrived in 2026: how the new pills work, trial results, costs and what changes for patients.
Read article
Nausea, fatigue, hair shedding and the rare serious risks of tirzepatide, with management strategies that work.
Read article
The plain-English guide to the weight-loss medications everyone is searching for, and the questions to ask first.
Read article
The constant mental chatter about food, explained: the science, the GLP-1 silence, and evidence-based ways to turn the volume down.
Read article
Oily stools, urgency and the internet's legends: what actually happens on orlistat, why, and how to prevent all of it.
Read article
Cravings pill vs appetite pens: a practical decision guide comparing mechanisms, results, costs and fit.
Read article
Tirzepatide vs semaglutide head to head: trial results, side effects, costs and how the 2026 lineup really stacks up.
Read article
No supplement mimics the pens, but your body makes GLP-1 every day. The foods and habits that genuinely raise it, and the claims to ignore.
Read article
The distinctive side-effect profile of phentermine-topiramate, from paresthesia to the pregnancy rule.
Read article
From nausea and fatigue to rare serious risks: a complete, honest guide to semaglutide side effects, duration and warning signs.
Read article
Nausea, insomnia, the boxed warning and the opioid rule: the complete safety guide to naltrexone-bupropion.
Read article
Muscle loss, hormones, sleep and life stage: why the same habits produce different results after 40.
Read article
Same molecule, different labels: doses, approvals, insurance, results and how doctors actually choose between them.
Read article
Six doses, four-week steps and the logic of tirzepatide titration: how prescribers find your right rung.
Read article
The foods that trigger nausea, the ones that protect muscle, and how to eat well on a suppressed appetite.
Read article
The only OTC-available weight-loss medication: mechanism, honest 3 to 5 percent results and the fat rule that runs everything.
Read article
Average 5 to 8 percent loss at 56 weeks: what Saxenda realistically delivers, for whom, and when it is enough.
Read article
Naltrexone plus bupropion targets cravings in the brain, not hormones in the gut. Who it helps and what to expect.
Read article
Why protein quietly outperforms most weight-loss tricks, and how much you actually need.
Read article
The strongest approved weight-loss pill: mechanism, 8 to 10 percent averages, dosing tiers and who it suits.
Read article
Forget crash diets. The evidence-backed fundamentals of losing weight in a way you can sustain.
Read article
Starvation mode, magic metabolism boosters and other myths, corrected with what the science actually shows.
Read article
How GLP-1 medications changed the weight-loss conversation in the US and UK, and what it means for everyday metabolic health.
Read articleAll content is evidence-informed and for general information only, not medical advice. We may earn an affiliate commission on some links, which never affects our editorial conclusions.
